Entities / Company
Globus Medical.
company
- Reports this week
- 1
- Active events
- 1
- Connections
- 47
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
One to three months ago
-
A company incubated at Duke University and based in Durham acquired digital healthcare company Higgs Boson.Some support2 reports
-
Globus Medical is headquartered in Audubon, Pennsylvania, and operates within the state.Some support1 report
-
Royal Bank of Canada raised its target price and gave an outperform rating for Globus Medical. Needham & Company also increased its target price and gave a buy rating.Some support2 reports
Gone quiet
No new reports in 90+ days-
Globus Medical disclosed position changes to the SEC, coinciding with Truist Financial setting a stock price target.Some support1 report
-
Globus Medical filed a disclosure with the SEC regarding a director's insider sale of company stock.Some support1 report
-
Atlassian, Globus Medical, and AppLovin are noted for their respective activities in the US market as of June 25, 2025.Speculative1 report
-
Discussions involving Globus Medical and NuVasive covered supply chain disruptions, financing trends, and tariff impacts.Speculative1 report
-
MedRhythms appointed a new CEO and CSO, and CMS assigned benefit categories and HCPCPCS codes.Speculative1 report
-
Carlsmed's custom medical devices are entering a competitive market against products from Johnson & Johnson, Globus Medical, and Medtronic plc.Some support1 report
-
Globus Medical led the acquisition of NuVasive in July 2025.Some support1 report
-
Globus Medical, EBC, and Stratasys are technology companies involved in advanced medical fields, with banking services tied to Rhode Island.Some support1 report
-
Globus Medical closed its acquisition of Nevro on August 8, 2025.Some support1 report
-
Sotera Health Company and Globus Medical are noted for innovating in drug development and advanced medical devices.Some support2 reports1 development inside
-
Keith Pfeil was appointed CEO of Globus Medical on August 11, 2025.Well supported6 reports
-
A market rally was fueled by positive inflation data on August 13, 2025, involving Globus Medical, Dentsply Sirona, UFP Technologies, and NeoGen.Some support1 report
-
Globus Medical's Price-to-Earnings ratio was reported to be lower than the industry average on August 27, 2025.Some support1 report
-
Life Spine (Q104480972) has been involved in patent disputes, including infringing on Globus Medical's (Q18344949) claims, while Globus itself has pending litigation against Alphatec.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Globus Medical this week
News at the entities that move Globus Medical most-
Needham & Company Mentioned togetherSEC is overseeing public offering filings involving Broadridge Financial Solutions.Moves Globus Medical
-
Royal Bank of Canada Mentioned togetherRoyal Bank of Canada raised its holdings in the Dimensional US Sustainability Core 1 ETF on June 19, 2026.Moves Globus Medical
-
Truist Financial Mentioned togetherMarketBeat aggregates data on Inventiva's stock, and Truist Financial has started coverage of the company.Moves Globus Medical
-
SEC StructuralDHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Moves Globus Medical
-
Pennsylvania Shared contextA Gallup poll measured opposition to data centers in the state of Pennsylvania.Moves Globus Medical
-
Securities and Exchange Commission StructuralBlackRock, the manager of the iShares Core MSCI EAFE ETF, has made required filings with the Securities and Exchange Commission regarding institutional holdings.Moves Globus Medical
Connections
The 11 strongest of 47, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
NuVasive Structural
Globus Medical acquired NuVasive, resulting in NuVasive becoming an integrated subsidiary of Globus Medical.
-
Pfeil Structural
Pfeil holds the formal role of CEO at Globus Medical, defining a structural leadership relationship.
-
Securities and Exchange Commission Structural
Globus Medical operates under the regulatory oversight and disclosure requirements of the U.S. Securities and Exchange Commission.
-
SEC Structural
Globus Medical is subject to regulatory oversight and must file disclosures with the SEC.
-
David Davidar Structural
David Davidar serves as a director of Globus Medical, which is the company whose shares he sold.
-
Needham & Company Mentioned together
Needham & Company issued a buy rating and raised the target price for Globus Medical.
-
Royal Bank of Canada Mentioned together
Royal Bank of Canada provides analyst reports and target price ratings regarding Globus Medical's market standing.
-
Pennsylvania Shared context
Globus Medical operates within the geographical and regulatory context of the state of Pennsylvania.
Show all 11 connections
-
representative Transactional
The representative engaged in buying and selling shares of Globus Medical.
-
Truist Financial Mentioned together
Truist Financial provided a stock price target for Globus Medical.
-
Audubon Shared context
Globus Medical is headquartered in Audubon.
History
Events by the month they beganSeptember 2026
3 events- Medtronic is ramping up its Hugo RAS system to compete with Intuitive Surgical, while its neuroscience unit faces competitive pressure from Stryker and Globus Medical.
- Globus Medical and TELA Bio are competing healthcare companies seeking investment.
- Globus Medical announced the expansion of its Excelsius Ecosystem capabilities and received CE mark clearance for commercial sales.
August 2026
2 eventsShow 1 earlier month
June 2026
14 events- Globus Medical disclosed position changes to the SEC, coinciding with Truist Financial setting a stock price target.
- Globus Medical filed a disclosure with the SEC regarding a director's insider sale of company stock.
- Atlassian, Globus Medical, and AppLovin are noted for their respective activities in the US market as of June 25, 2025.
- Discussions involving Globus Medical and NuVasive covered supply chain disruptions, financing trends, and tariff impacts.
- MedRhythms appointed a new CEO and CSO, and CMS assigned benefit categories and HCPCPCS codes.
- Carlsmed's custom medical devices are entering a competitive market against products from Johnson & Johnson, Globus Medical, and Medtronic plc.
- Globus Medical led the acquisition of NuVasive in July 2025.
- Globus Medical, EBC, and Stratasys are technology companies involved in advanced medical fields, with banking services tied to Rhode Island.
- Globus Medical closed its acquisition of Nevro on August 8, 2025.
- Sotera Health Company and Globus Medical are noted for innovating in drug development and advanced medical devices.
- Keith Pfeil was appointed CEO of Globus Medical on August 11, 2025.
- A market rally was fueled by positive inflation data on August 13, 2025, involving Globus Medical, Dentsply Sirona, UFP Technologies, and NeoGen.
- Globus Medical's Price-to-Earnings ratio was reported to be lower than the industry average on August 27, 2025.
- Life Spine (Q104480972) has been involved in patent disputes, including infringing on Globus Medical's (Q18344949) claims, while Globus itself has pending litigation against Alphatec.